Barclays’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,520,000
Closed -$88.3M 5435
2024
Q2
$88.3M Buy
+8,520,000
New +$93.4M 0.03% 430
2020
Q3
Sell
-2,900
Closed -$10K 5499
2020
Q2
$10K Sell
2,900
-1,600
-36% -$5.52K ﹤0.01% 5326
2020
Q1
$11K Sell
4,500
-4,600
-51% -$29.8K ﹤0.01% 5794
2019
Q4
$96K Buy
9,100
+4,600
+102% +$41.6K ﹤0.01% 5501
2019
Q3
$38K Sell
4,500
-33,100
-88% -$325K ﹤0.01% 6016
2019
Q2
$433K Buy
37,600
+33,600
+840% +$432K ﹤0.01% 4453
2019
Q1
$56K Buy
4,000
+700
+21% +$9.18K ﹤0.01% 5787
2018
Q4
$34K Sell
3,300
-5,800
-64% -$85.5K ﹤0.01% 5675
2018
Q3
$156K Sell
9,100
-1,900
-17% -$32.6K ﹤0.01% 5194
2018
Q2
$198K Sell
11,000
-27,200
-71% -$545K ﹤0.01% 4734
2018
Q1
$669K Sell
38,200
-54,400
-59% -$1.14M ﹤0.01% 3658
2017
Q4
$2.13M Buy
92,600
+7,800
+9% +$162K ﹤0.01% 2370
2017
Q3
$1.78M Buy
84,800
+51,800
+157% +$954K ﹤0.01% 2471
2017
Q2
$666K Buy
33,000
+30,500
+1,220% +$664K ﹤0.01% 3242
2017
Q1
$61K Sell
2,500
-64,800
-96% -$1.75M ﹤0.01% 5216
2016
Q4
$1.81M Sell
67,300
-8,000
-11% -$198K ﹤0.01% 2210
2016
Q3
$1.68M Sell
75,300
-125,200
-62% -$2.51M ﹤0.01% 2140
2016
Q2
$4.28M Buy
200,500
+2,200
+1% +$41.4K 0.01% 1432
2016
Q1
$3.37M Buy
198,300
+144,000
+265% +$2.15M 0.01% 1483
2015
Q4
$815K Buy
54,300
+53,500
+6,688% +$823K ﹤0.01% 2788
2015
Q3
$10K Sell
800
-75,900
-99% -$1.2M ﹤0.01% 5779
2015
Q2
$1.38M Buy
76,700
+39,500
+106% +$819K ﹤0.01% 2581
2015
Q1
$670K Sell
37,200
-131,600
-78% -$2.26M ﹤0.01% 3316
2014
Q4
$2.7M Buy
168,800
+71,800
+74% +$1.51M ﹤0.01% 2253
2014
Q3
$3.1M Sell
97,000
-58,100
-37% -$1.97M ﹤0.01% 2253
2014
Q2
$5.27M Buy
155,100
+142,100
+1,093% +$4.67M 0.01% 1690
2014
Q1
$403K Sell
13,000
-33,600
-72% -$934K ﹤0.01% 4136
2013
Q4
$1.17M Buy
46,600
+18,700
+67% +$448K ﹤0.01% 3226
2013
Q3
$586K Sell
27,900
-5,200
-16% -$107K ﹤0.01% 3934
2013
Q2
$641K Buy
+33,100
New +$722K ﹤0.01% 3924

Other funds holding PTEN

Barclays's PTEN Position: Q1 2026 in Review

Barclays increased its Patterson-UTI (PTEN) stake by 75% in Q1 2026, buying an estimated $7.17M and bringing the position to 1,956,581 shares worth $21.2M. The position accounts for 0.01% of the portfolio, ranked #1073.

Barclays first reported a position in PTEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.3M in Q2 2024. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Barclays held 1,956,581 shares of Patterson-UTI worth $21.2M as of Q1 2026.
  • Barclays bought 838,091 Patterson-UTI shares in Q1 2026, an estimated $7.17M.
  • Patterson-UTI made up 0.01% of Barclays's portfolio in Q1 2026, its #1073 holding.
  • Barclays first reported a position in Patterson-UTI in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Patterson-UTI position peaked at $27.3M in Q2 2024.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.